Related Experiment Video
Updated: May 6, 2026

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
The gut microbiome as novel cardio-metabolic target: the time has come!
Sarah Vinjé1, Erik Stroes, Max Nieuwdorp
1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, AMC-UvA, Meibergdreef 9, room F4-159.2, 1105 AZ Amsterdam, The Netherlands.
Abstract:
Recent studies reveal a potential contribution of intestinal microbes in the expression of certain human cardio-metabolic diseases. The mechanisms through which intestinal microbiota and/or their metabolic products alter systemic homoeostasis and cardio-metabolic disease risks are just beginning to be dissected. Intervention studies in humans aiming to either selectively alter the composition of the intestinal microbiota or to pharmacologically manipulate the microbiota to influence production of their metabolites are crucial next steps. The intestinal microbiome represents a new potential therapeutic target for the treatment of cardio-metabolic diseases.
Related Concept Videos
Functions of the Gut Microbiota
Introduction to the Human Microbiota
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Gut-Brain Axis
Development of Human Microbiota

